These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 24752590)

  • 21. Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain.
    Perluigi M; Pupo G; Tramutola A; Cini C; Coccia R; Barone E; Head E; Butterfield DA; Di Domenico F
    Biochim Biophys Acta; 2014 Jul; 1842(7):1144-53. PubMed ID: 24735980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RCAN1-mediated calcineurin inhibition as a target for cancer therapy.
    Lao M; Zhang X; Yang H; Bai X; Liang T
    Mol Med; 2022 Jun; 28(1):69. PubMed ID: 35717152
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do RCAN1 proteins link chronic stress with neurodegeneration?
    Ermak G; Pritchard MA; Dronjak S; Niu B; Davies KJ
    FASEB J; 2011 Oct; 25(10):3306-11. PubMed ID: 21680892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation.
    Qiu K; Wang S; Wang X; Wang F; Wu Y
    Biomed Res Int; 2020; 2020():1920789. PubMed ID: 32566665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase A phosphorylates Down syndrome critical region 1 (RCAN1).
    Kim SS; Oh Y; Chung KC; Seo SR
    Biochem Biophys Res Commun; 2012 Feb; 418(4):657-61. PubMed ID: 22293192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of tau protein in Alzheimer's disease: The prime pathological player.
    Muralidar S; Ambi SV; Sekaran S; Thirumalai D; Palaniappan B
    Int J Biol Macromol; 2020 Nov; 163():1599-1617. PubMed ID: 32784025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulator of calcineurin 1 modulates expression of innate anxiety and anxiogenic responses to selective serotonin reuptake inhibitor treatment.
    Hoeffer CA; Wong H; Cain P; Levenga J; Cowansage KK; Choi Y; Davy C; Majmundar N; McMillan DR; Rothermel BA; Klann E
    J Neurosci; 2013 Oct; 33(43):16930-44. PubMed ID: 24155299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease.
    Narayanan SE; Sekhar N; Rajamma RG; Marathakam A; Al Mamun A; Uddin MS; Mathew B
    Curr Protein Pept Sci; 2020; 21(12):1164-1173. PubMed ID: 32957903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models.
    Götz J; Schild A; Hoerndli F; Pennanen L
    Int J Dev Neurosci; 2004 Nov; 22(7):453-65. PubMed ID: 15465275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease.
    Cook CN; Hejna MJ; Magnuson DJ; Lee JM
    J Alzheimers Dis; 2005 Sep; 8(1):63-73. PubMed ID: 16155351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration.
    Porta S; Serra SA; Huch M; Valverde MA; Llorens F; Estivill X; Arbonés ML; Martí E
    Hum Mol Genet; 2007 May; 16(9):1039-50. PubMed ID: 17341486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of Oxidative Stress and Synapse Dysfunction in the Pathogenesis of Alzheimer's Disease: Understanding the Therapeutics Strategies.
    Kamat PK; Kalani A; Rai S; Swarnkar S; Tota S; Nath C; Tyagi N
    Mol Neurobiol; 2016 Jan; 53(1):648-661. PubMed ID: 25511446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease.
    Blazquez-Llorca L; Garcia-Marin V; Merino-Serrais P; Ávila J; DeFelipe J
    J Alzheimers Dis; 2011; 26(4):683-98. PubMed ID: 21677375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GSK3 and tau: two convergence points in Alzheimer's disease.
    Hernandez F; Lucas JJ; Avila J
    J Alzheimers Dis; 2013; 33 Suppl 1():S141-4. PubMed ID: 22710914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperphosphorylation of Tau induced by naturally secreted amyloid-β at nanomolar concentrations is modulated by insulin-dependent Akt-GSK3β signaling pathway.
    Tokutake T; Kasuga K; Yajima R; Sekine Y; Tezuka T; Nishizawa M; Ikeuchi T
    J Biol Chem; 2012 Oct; 287(42):35222-35233. PubMed ID: 22910909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A hidden incoherent switch regulates RCAN1 in the calcineurin-NFAT signaling network.
    Shin SY; Yang HW; Kim JR; Heo WD; Cho KH
    J Cell Sci; 2011 Jan; 124(Pt 1):82-90. PubMed ID: 21172821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.